AGEBOX Launches iKids-Growth – A Hormone-Free Breakthrough for Children Falling Behind in Height

RICHMOND, VA / ACCESS Newswire / August 6, 2025 / AGEBOX, a U.S.-based biotech company focused on children’s health, has introduced iKids-Growth, the first supplement that helps children reach their height potential by supporting the body’s natural production and use of IGF-1 – a key growth factor. In today’s healthcare systems, hormone-based treatments such as […]

Clearway Energy, Inc. Announces $100,000,000 At-The-Market (ATM) Equity Offering Program

(NYSE:CWEN),(NYSE:CWEN.C),(NYSE:CWEN-C),(NYSE:CWEN.A),(NYSE:CWEN-A), PRINCETON, N.J., Aug. 06, 2025 (GLOBE NEWSWIRE) — Clearway Energy, Inc. (NYSE: CWEN, CWEN.A) (the “Company” or “Clearway Energy”), today announced a $100,000,000 At-The-Market (“ATM”) equity offering program and announced that it and Clearway Energy LLC entered into an Equity Distribution Agreement (the “Agreement”) with Morgan Stanley, BofA Securities, Citigroup, J.P. Morgan and Wells

Clearway Energy, Inc. Announces $100,000,000 At-The-Market (ATM) Equity Offering Program

Clearway Energy, Inc. Announces $100,000,000 At-The-Market (ATM) Equity Offering Program GlobeNewswire August 06, 2025 PRINCETON, N.J., Aug. 06, 2025 (GLOBE NEWSWIRE) — Clearway Energy, Inc. (NYSE: CWEN, CWEN.A) (the “Company” or “Clearway Energy”), today announced a $100,000,000 At-The-Market (“ATM”) equity offering program and announced that it and Clearway Energy LLC entered into an Equity Distribution

Helix Acquisition Corp. II Retains More than 60% of Trust Account after Redemptions in connection with Business Combination with BridgeBio Oncology Therapeutics

(NasdaqGM:HLXB),(NASDAQ:BBIO), Gross proceeds of approximately $120 million from trust account and approximately $261 million from PIPE financing to be available to the combined company at the closing 2nd lowest redemption rate for a biotech de-SPAC transaction since 2022 BOSTON & SOUTH SAN FRANCISCO, Aug. 06, 2025 (GLOBE NEWSWIRE) — Helix Acquisition Corp. II (“Helix”) (Nasdaq:

Investors in Novo Nordisk A/S (NVO): Protect Your Rights – Contact Levi & Korsinsky Before September 30, 2025

NEW YORK, NY / ACCESS Newswire / August 6, 2025 / If you suffered a loss on your Novo Nordisk A/S (NYSE:NVO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/novo-nordisk-a-s-lawsuit-submission-form-3?prid=159929&wire=1&utm_campaign=11 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

Levi & Korsinsky Urges Flywire Corporation (FLYW) Shareholders to Act Before Lead Plaintiff Deadline September 23, 2025

NEW YORK, NY / ACCESS Newswire / August 6, 2025 / If you suffered a loss on your Flywire Corporation (NASDAQ:FLYW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/flywire-corporation-lawsuit-submission-form?prid=159928&wire=1&utm_campaign=18 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

Helix Acquisition Corp. II Retains More than 60% of Trust Account after Redemptions in connection with Business Combination with BridgeBio Oncology Therapeutics

Helix Acquisition Corp. II Retains More than 60% of Trust Account after Redemptions in connection with Business Combination with BridgeBio Oncology Therapeutics GlobeNewswire August 06, 2025 Gross proceeds of approximately $120 million from trust account and approximately $261 million from PIPE financing to be available to the combined company at the closing 2nd lowest redemption

Did Otis Worldwide Corporation Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate – OTIS

NEW YORK, NY / ACCESS Newswire / August 6, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Otis Worldwide Corporation ("Otis Worldwide Corporation") (NYSE:OTIS) concerning possible violations of federal securities laws. On July 23, 2025, Otis reported its second quarter fiscal 2025 earnings, unveiling net sales for the quarter

Levi & Korsinsky Announces an Investigation on Behalf of Encompass Health Corporation (EHC) Shareholders Who May Have Been Affected by Fraud

NEW YORK, NY / ACCESS Newswire / August 6, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Encompass Health Corporation ("Encompass Health Corporation") (NYSE:EHC) concerning possible violations of federal securities laws. On July 15, 2025, the New York Times published an article, entitled "Even Grave Errors at Rehab Hospitals

Inspired Reports Second Quarter 2025 Results

(NASDAQ:INSE), Revenue of $80.3 million, up 7% over prior year, driven primarily by record Interactive revenue, up 45% year-over-year Net Operating Income of $7.9 million, Net Loss of $7.8 million and Adjusted Net Loss of $5.6 million Adjusted EBITDA of $28.4 million, up 15% from last year driven by record Interactive Adjusted EBITDA, up 49%

Scroll to Top